Doxorubicin and Adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
A new interesting article has been published in Acta Biomater. 2019 May 26. pii: S1742-7061(19)30388-5. doi: 10.1016/j.actbio.2019.05.061. and titled: Doxorubicin and Adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant…